IBT Staff Reporter

118711-118740 (out of 154945)

Harrelson, Murray bring flair to Zombieland

Falling closer in tone to Shaun of the Dead than 28 Days Later or the George Romero movies, Zombieland has its tongue planted firmly in its rancid cheek while still delivering the visceral goodies.

Trauma stands out among new fall TV shows

NBC's primetime lineup is already laden with cop and hospital dramas, so it hardly seems necessary to add yet another to the schedule. And initially, the new medical series Trauma seems to be the same old tune, different verse.

Abbott, Johnson & Johnson bulk up in Europe

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.

Negotiators urged to speed up climate pact talks

Delegates at the start of marathon climate talks in Thailand on Monday were told to speed up painfully slow negotiations as they struggle to settle on the outline of a tougher pact to fight global warming.

UK Stocks -- Factors to watch on Sept 28

Britain's FTSE 100 .FTSE index is seen opening 7 to 15 points, or as much as 0.3 percent lower on Monday, according to financial bookmakers, tracking weaker showings in Asia after falls on Wall Street on Friday, with investors nervously looking ahead to this week U.S. jobs report.

KT sees iPhone impact, to offer new phones

South Korea's KT Corp, which is holding talks to sell Apple's iPhone in South Korea, plans to introduce 3G smartphones supporting WiFi and mobile WiMAX from Samsung Electronics and LG Electronics, its chief strategy officer told Reuters.

BofA suspends ACORN commitments- WSJ

Bank of America Corp has suspended its current commitments to ACORN Housing, an affiliate of Association of Community Organizations for Reform Now, a scandal-hit U.S. liberal grassroots group, the Wall Street Journal said on Monday.

Johnson & Johnson buys 18 percent stake in Crucell

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.

Australia court allows claims against Lehman

An Australian court has ruled that local governments can pursue financial claims against collapsed U.S. investment bank Lehman Brothers in Australia and elsewhere, a firm that is funding the litigation said on Monday.

Oil falls below $66, sluggish demand in focus

Oil fell below $66 a barrel on Monday, extending last week's 8.4 percent drop, as investors focused on high inventories and sluggish demand, shrugging off tension between Iran and the West.

Early detection enhances lymphoedema treatment

Early detection of problems in the lymphatic system is the best way to prevent the discomfort and disfigurement that can result from lymphoedema, the swelling created by disruption to the body's drainage system.

Expert comment on iSnack2.0

The name chosen by Kraft for its new Vegemite - iSnack2.0 - has been widely panned in online commentary from the public.

BofA suspends ACORN commitments: report

Bank of America Corp has suspended its current commitments to ACORN Housing, an affiliate of Association of Community Organizations for Reform Now , a scandal-hit U.S. liberal grassroots group, the Wall Street Journal said on Monday.

Unicom to sell iPhones in China from October

China Unicom, the country's No.2 mobile carrier, said on Monday that Apple's popular iPhone will retail in China for 5,000 yuan ($732.50), above market expectation, as it seeks to build up its 3G service.

Yen surge hits Japan shares, risky assets retreat

The yen surged to an eight-month high against the dollar on Monday as Japanese officials waved off any plans to stem the currency's rise, driving the Nikkei down 2.5 percent and sparking a broad retreat from riskier assets.

Solvay sells drugs unit to Abbott for $6.6 billion

Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.

Abbott to buy Solvay unit for $6.6 billion: sources

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.

Pages